Professor Jacques Miller a member of Cartherics’ Scientific Advisory Board wins “The Japan Prize Foundation says Walter and Eliza Hall Institute’s Prof Jacques Miller and Emory’s Prof Max Cooper have won the Japan Prize for Medical and Medicinal Science. A spokesperson for the Foundation told Biotech Daily that Prof Miller and Dr Cooper would share the […]
Immunotherapy : Professor Alan Trounson and Professor Richard Boyd started the future of cancer treatment at the Monash Health Translation Precinct.
29 May 2018, Hudson Institute of Medical Research
‘Off-the-shelf’ immunotherapies to fight aggressive forms of cancer, including relapsed ovarian and gastric cancers, are being developed in Clayton, Melbourne, thanks to almost $3 million in Federal Government funding awarded to lead participant Cartherics Pty Ltd.
‘Off the shelf cancer hope as rare cell becomes tumour buster’
Victorian State Government Awards Cartherics Pty Ltd a Victorian Medical Research Acceleration Fund (VMRAF) Grant for AU$500,000
Finding a treatment for ovarian cancer – Cartherics Pty Ltd ($500,000)
Read more here ….. 171031-New-Research-To-Fast-Track-Medical-Breakthroughs
Ovarian cancer is the sixth most common cause of cancer-related death in Australian women and is the fifth most common […]
Cartherics’ mission is the development of novel, immune cell therapy products for the treatment of cancer, endometriosis and Alzheimer’s disease.
Stay informed about our latest news and developments
© Copyright 2022 | Cartherics Pty ltd